Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase Inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT
Nom du journal : J Clin Oncol
Année : 2008
Volume : 26
Page de départ : 1664
Page de fin : 1670